started semax about six weeks ago, 0.1mg intranasal, two doses on work days. the target was task initiation, which for me looks like opening a brief and then spending 40 minutes on youtube instead. first week felt like something. less friction in the morning, quicker to get into actual work. but here’s where it falls apart as data: i also cut caffeine the same week because my sleep was properly cooked, and i started 20-minute morning walks on my physiotherapist’s advice for the wrist rehab. so what i actually logged wasn’t “semax improved focus.” it was “semax plus reduced caffeine plus morning aerobic activity improved something i’m calling focus.” three stacked variables. i know this exact problem because i’ve been calling it out in other people’s bpc posts for months and here i am doing the same thing. the measurement gap i keep running into: “focus” as a daily self-report is probably the worst proxy metric in the nootropic space. what my log is actually capturing is “did i feel productive today, yes or no.” that’s not BDNF upregulation. that’s mood, sleep quality, and maybe what i had for lunch. the bdnf angle is genuinely interesting in the animal literature but the translational leap to “sharper task initiation in a graphic designer at 0.1mg” is doing a lot of work. i’m not saying it’s not real, i’m saying the mechanism story and the felt experience are not the same measurement and people conflate them constantly. still running it. the task initiation thing does seem to have held past the novelty window, which is more than i can say for half the things i’ve tried. tracking it daily in careclinic - the dark mode chart tuning is actually good, doesn’t strain to read at midnight when i’m reviewing the week, so i check it more often than i otherwise would. week eight is probably when i’ll have anything worth saying. maybe.